Lactocepin as a protective microbial structure in the context of IBD.

about

Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.The microbiome and psoriatic arthritis.

P2860

Q26752511-8858C97E-14C8-4177-AAC1-2E68F4A7C601 Q35271319-26AA8560-2B82-40DB-B914-60837FA142A6 Q38182899-DE8D4A9F-DF42-4749-84E4-CA109A4D98F4

P2860

Lactocepin as a protective microbial structure in the context of IBD.

Item

http://www.wikidata.org/entity/Q38075379

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Lactocepin as a protective microbial structure in the context of IBD.

@en

type

Item

label

Lactocepin as a protective microbial structure in the context of IBD.

@en

prefLabel

Lactocepin as a protective microbial structure in the context of IBD.

@en

P1476

Lactocepin as a protective microbial structure in the context of IBD.

@en

P2093

Gabriele Hörmannsperger

http://www.w3.org/2001/XMLSchema#string

Marie-Anne von Schillde

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

A human gut microbial gene catalogue established by metagenomic sequencing

A microbial symbiosis factor prevents intestinal inflammatory disease

Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota

Bifidobacteria can protect from enteropathogenic infection through production of acetate

Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.

Multi-domain, cell-envelope proteinases of lactic acid bacteria.

Safety assessment of probiotics for human use.

Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.

P304

152-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/GMIC.23444

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dirk Haller

P577

2013-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234700718

http://www.w3.org/2001/XMLSchema#string

P698

23333860

http://www.w3.org/2001/XMLSchema#string

P932

3595076

http://www.w3.org/2001/XMLSchema#string

Lactocepin as a protective microbial structure in the context of IBD.

about

P2860

P2860

Lactocepin as a protective microbial structure in the context of IBD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932